Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare ...

The mega processor may sell assets after the Worldpay purchase revised its outlook. The company also expects Trump tax ...

Surmodics remains in the midst of being acquired by GTCR, with completion pending regulatory approval. The $43.00-per-share all-cash deal offers potential liquidity for shareholders, but litigation by ...